BridgeMD
New treatment option for Dry Eye Syndrome (DES)
Official title Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops.
ClinicalTrials.gov ID: NCT07632534
What this study is testing
- What it's testing
- Dry eye syndrome is a multifactorial pathology of the ocular surface. Epidemiological studies report a prevalence of 15% in adults aged between 50 and 95.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age over 18 years
- Patients with severe dry eye with an Oxford score \> 1
- Patients with dry eye syndrome refractory to conventional treatments: tear substitutes, immunosuppressive eye drops or corticosteroids.
- AS-naïve patients followed by an ophthalmologist at Saint-Etienne University Hospital
- Patients affiliated to or entitled under a social security scheme
You likely can't join if
- Severe ocular dryness due to a genetic disease
- Patients not under the care of an ophthalmologist at Saint-Etienne University Hospital.
- Patients not eligible for treatment with AS (pregnant women, anaemia, current infection, progressive disease, serological results contraindicating...
- Patients under protective measures
See the full eligibility criteria
- Age over 18 years
- Patients with severe dry eye with an Oxford score \> 1
- Patients with dry eye syndrome refractory to conventional treatments: tear substitutes, immunosuppressive eye drops or corticosteroids.
- AS-naïve patients followed by an ophthalmologist at Saint-Etienne University Hospital
- Patients affiliated to or entitled under a social security scheme
- Patients who have received informed information about the study
- Severe ocular dryness due to a genetic disease
- Patients not under the care of an ophthalmologist at Saint-Etienne University Hospital.
- Patients not eligible for treatment with AS (pregnant women, anaemia, current infection, progressive disease, serological results contraindicating blood sampling).
- Patients under protective measures
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Etienne, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Etienne, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.